ProfileGDS5678 / 1454188_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 51% 52% 51% 50% 51% 51% 55% 51% 50% 51% 52% 52% 51% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2802751
GSM967853U87-EV human glioblastoma xenograft - Control 23.2701952
GSM967854U87-EV human glioblastoma xenograft - Control 33.239651
GSM967855U87-EV human glioblastoma xenograft - Control 43.1505250
GSM967856U87-EV human glioblastoma xenograft - Control 53.1891751
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.329651
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.471155
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2192651
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1783650
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1955651
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2407752
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2218552
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.242151
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2573952